Acute angle closure glaucoma precipitated by homeopathic eyedrops containing Atropa belladonna. by Huff, Mallorie L et al.
Lehigh Valley Health Network 
LVHN Scholarly Works 
Department of Emergency Medicine 
Acute angle closure glaucoma precipitated by homeopathic 
eyedrops containing Atropa belladonna. 
Mallorie L Huff 
Derek Fikse 
Ryan M Surmaitis 
Marna Rayl Greenberg 
Follow this and additional works at: https://scholarlyworks.lvhn.org/emergency-medicine 
 Part of the Emergency Medicine Commons, and the Medical Toxicology Commons 
This Article is brought to you for free and open access by LVHN Scholarly Works. It has been accepted for inclusion 
in LVHN Scholarly Works by an authorized administrator. For more information, please contact 
LibraryServices@lvhn.org. 
Acute angle closure glaucoma precipitated by homeopathic eyedrops
containing Atropa belladonna
Mallorie L. Huff, BS ⁎, Derek Fikse, DO, Ryan M. Surmaitis, DO, Marna Rayl Greenberg, DO MPH
Lehigh Valley Health Network, Department of Emergency and Hospital Medicine/USF, Morsani College of Medicine, Cedar Crest Boulevard & I-78, Allentown, PA 18103, USA
a b s t r a c ta r t i c l e i n f o
Article history:
Received 26 August 2021
Received in revised form 27 September 2021
Accepted 28 October 2021
Available online xxxx
Acute angle closure glaucoma is a sight-threatening condition thatmay lead to blindness. This is a case report of a
womanwhopresented to the emergency department (ED)with acute angle closure glaucoma followinguse of an
over-the-counter (OTC) homeopathic eye drop containing atropa belladonna (deadly nightshade).
A 55-year-oldwoman presented to the EDwith a 5-day history of left eye redness, swelling, tearing, and foreign-
body sensation that had acutelyworsened in the last two days. Her exam revealedmild left conjunctival injection
withwatery tearing and a hazy appearance of her left cornea. Fluorescein stainingwas negative, while tonometry
revealed elevated intraocular pressure on the left, suggestive of acute angle closure glaucoma. She was urgently
referred to ophthalmology. The etiology of the acute angle closure glaucoma was initially unclear however, with
additional prompting, she revealed that two days prior she had startedusinghomeopathicOTC eye drops. Inspec-
tion of the eyedrop's ingredients revealed that atropa belladonna was the primary ingredient and likely precipi-
tated her isolated episode of acute angle closure glaucoma.
A high level of clinical suspicion and focused ophthalmic exam including tonometry is essential to identify acute
angle closure glaucoma in the ED. We present a case report of acute angle closure glaucoma associated with the
use of homeopathic belladonna-containing eyedrops. Our report reinforces the necessity to perform thorough
medication and supplement history given the prevalence of physiologically active substances available in OTC
medications.
© 2021 Elsevier Inc. All rights reserved.
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Acute angle closure glaucoma is a sight-threatening condition that
may lead to blindness. A high level of clinical suspicion with confirma-
tional testing should be followed by anurgent referral to ophthalmology
to minimize patient morbidity related to persistently increased intraoc-
ular pressures. We present a case report of a woman who presented to
the emergency department (ED) with acute angle closure glaucoma
following use of an over-the-counter (OTC) homeopathic eye drop.
2. Case description
A 55-year-oldwomanwith history significant forwell-controlled di-
abetesmellitus and primary hypertension presented to the EDwith a 5-
day history of left eye redness, swelling, tearing, and foreign-body
sensation that acutely worsened over the last two days. She was evalu-
ated by her ophthalmologist when her symptoms first began –it is
unknown whether this exam included tonometry with documented
normal intra-ocular pressure—but by patient report the examination
was noted to have no abnormal findings. Shewas told she should return
if symptoms persisted. She denied a history of trauma, recent upper re-
spiratory infection, previous eye injury, or conjunctivitis exposure. She
denied fever, chills, headache, dizziness, loss of vision, painful eye
movements, photophobia, or blurred vision. She wore glasses but not
contacts. Her past relevant surgical history included LASIK eye surgery
15 years prior.
On presentation, she appeared nontoxic and, aside from an elevated
blood pressure of 146/104, her vital signs were within normal limits for
her age. Her physical exam was significant for mild left conjunctival
injection with clear, watery tearing and a hazy appearance of her left
cornea. Her extraocular movements were nonpainful, fully intact, and
equal bilaterally. At baseline, her pupils were not miotic or mydriatic
and were equal, round, and reactive to light. Ciliary flush was not pres-
ent. On digital palpation of the globe, her left felt firmer than the right.
Her visual acuitywas 20/20 bilaterally, 20/20 on the right, and 20/40
on the left. Fluorescein staining did not reveal evidence of any corneal
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abrasion or ulceration. On tonometry, her intraocular pressure was ele-
vated in her left eye (51 mmHg) compared to her right (11 mmHg). At
this time, acute angle glaucoma (AACG) being the definitive diagnosis,
an ophthalmologist was urgently consulted.
Given the seemingly unprovoked development of her AACG, a sec-
ondary review of medications and supplements was performed. While
our patient initially denied using any newmedications or supplements,
upon further prompting andwith use of amobile identification app, she
eventually endorsed starting cetirizine 5 days prior, left-over erythro-
mycin ointment 4 days prior, and a homeopathic remedy by Similasan
for “Pink Eye Relief” 2 days prior (Fig. 1). Upon review of the eyedrop's
ingredients, Belladonna 6×, Euphrasia officinalis (Eyebright) 6×, and
Hepar Sulphuris 12× were identified as key active ingredients (Fig. 2).
She was advised to inform her ophthalmologist about the belladonna-
containing eye drops andwas discharged from the ED for an immediate
outpatient ophthalmologic evaluation.
3. Discussion
A. belladonna, also known as deadly nightshade, is a plant containing
multiple alkaloids including atropine, hyocyamine, and scopolamine [1].
Atropine and these other alkaloids have potent antimuscarinic effects,
including cycloplegia and mydriasis. In fact, A. belladonna translates to
“beautiful woman” and historically was applied topically for its
eye-dilating properties which were viewed as aesthetically pleasing
[2]. Today, atropine has many FDA approved uses, most notably for cer-
tain bradyarrhythmias, organophosphate poisoning, and varying oph-
thalmologic uses.
AACG is a sight-threatening condition that requires a high degree
of clinical suspicion and rapid action to prevent vision loss in the af-
fected eyes. Medications known to cause acute angle closure crisis in-
clude a myriad of drug classes, including adrenergic agonists,
anticholinergics, cholinergics, histamine antagonists, among many
others [3]. Previous reports of over the counter (OTC) substances pre-
cipitating AACG have been described including ma-huang (ephedra)
and pseudoephedrine [4,5]. Similasin eye drops have been described
in a case of anisocoria; however, to our knowledge, this is the first de-
scription of AACG secondary to an OTC eyedrop containing belladonna
[6]. Systemic belladonna use causing bilateral AACG from an OTC cold
and flu remedy has also been reported. Similar to the Similasin eye-
drops, there was no product warning describing the possibility of
AACG [7].
Assessing potential drug-related adverse events can be a complex
issue and while validated scales may not always be helpful, some indi-
vidual elements may be useful in determining the association of drug
and reaction. While there has been evidence that belladonna can
cause this reaction and the adverse event appeared after the suspected
drug (OTC homeopathy eye drops) was administered, our lack of
follow-up for the patient would still yield a possible/probable reaction
on the Naranjo probability scale [7,8]. This is particularly true consider-
ing that cetirizine is generally considered to haveminimal anticholiner-
gic activity, albeit the literature does not reveal reported cases of AACG
related to cetirizine. Additionally it is unknown whether the patient
used the drops equally in both eyes, but it is notable that the tonometry
was asymmetrical.
Our study is unique in that our patient did not initially disclose her
use of OTC homeopathic eyedrops because she did not perceive them
as pharmacological therapy. Only after detailed retroactive history-
taking was it discovered that she had been using eyedrops containing
belladonna. While the exact amount of belladonna should have been
very small, OTC supplements andmedications do not require FDA regu-
lation and without standardized manufacturing processes could have
been greater than the concentration on the label implies. Our study
highlights the danger of allowing products with physiologically active
components to be freely sold.
4. Conclusion
Homeopathic treatments are non-regulated for safety and effec-
tiveness and widely accessible OTC. Most patients and clinicians as-
sume they are benign and do not appreciate their potential for
causing significant harm. This case highlights AACG, a serious adverse
effect, associated with the use of belladonna-containing eye drops. The
etiology was identified by performing a more thorough history of the
patient's medications. It is imperative to always review home medica-
tions with patients including OTC as it may provide useful clinical
information.
Fig. 1. Image of Similasan “Pink Eye Relief” eyedrops packaging. (For interpretation of the
references to colour in this figure legend, the reader is referred to the web version of this
article.)
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Fig. 2. Drug Facts of Similasan “Pink Eye Relief” eyedrop. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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